Celiac Disease News and Research

Latest Celiac Disease News and Research

Thought Leaders Consortium discusses new vision for medicine in healthcare

Defining a new vision for medicine was the mission of the consortium of global leaders in healthcare who gathered in Seattle, Wash., April 12 - 14 for the first "Thought Leaders Consortium" hosted by the Personalized Lifestyle Medicine Institute.

25 Apr 2013

Genetic study defines link between primary sclerosing cholangitis and other autoimmune diseases

Researchers have newly associated nine genetic regions with a rare autoimmune disease of the liver known as primary sclerosing cholangitis (PSC). This brings the total number of genetic regions associated with the disease to 16.

22 Apr 2013

New biochemical evidence shows cereal grain sorghum safe food for people with celiac disease

Strong new biochemical evidence exists showing that the cereal grain sorghum is a safe food for people with celiac disease, who must avoid wheat and certain other grains, scientists are reporting.

4 Apr 2013

Researchers discover new type of deadly intestinal lymphoma common in Asia

An international research team has identified a new type of deadly intestinal lymphoma that is particularly common in Asia. The team, led by clinician-scientists from the SingHealth Academic Healthcare Cluster, also developed a new diagnostic test to accurately identify these patients.

2 Apr 2013

LabCorp launches expanded IBD testing profile

Laboratory Corporation of America Holdings announced today the availability of an expanded testing menu to help clinicians diagnose, treat and monitor the course of Inflammatory Bowel Disease.

1 Apr 2013

GF foods lack vitamins and nutrients, can be high in fat and calories

In the ever-present search to identify and address bad nutrition habits, gluten-free eating has been receiving a lot of attention. But experts at the University of Alabama at Birmingham (UAB) say it is not to be confused with typical weight loss procedures.

29 Mar 2013

Avaxia initiates AVX-470 Phase 1b clinical study in ulcerative colitis

Avaxia Biologics, Inc., a clinical-stage biopharmaceutical company developing gut-targeted therapeutics, announced today that the first patient has been dosed in a Phase 1b clinical study of AVX-470, an oral anti-TNF antibody, for the treatment of ulcerative colitis.

25 Feb 2013

Introducing gluten-containing foods to breast-feeding infants may prevent celiac disease

Celiac disease is much more common in Sweden than in the rest of Europe and the U.S., but may be prevented with gradually introducing gluten-containing foods to breast-feeding infants, according to a comprehensive study led by researchers at Umeå University.

20 Feb 2013

SQI Diagnostics reports net loss of $1,563,000 for quarter-ended December 31, 2012

SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.

15 Feb 2013

Scientists identify aromatic rice with very low arsenic content

Millions of people worldwide are regularly exposed to arsenic through drinking water and eating rice grown in soil and water containing high amounts of arsenic. Long-term exposure can lead to the development of different types of cancer as well as serious cardiovascular, neurological, and other health problems. Scientists have now identified aromatic rice from Bangladesh that has far lower arsenic concentrations than found in non-aromatic rice.

13 Feb 2013

Infusions of regulatory T cells turn off autoimmune attack on joints

Farber Cancer Institute scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved treatment of arthritis and other autoimmune disorders in people.

10 Feb 2013

Beth Israel Deaconess Medical Center introduces CeliacNow website

It's estimated that one in 100 people in the United States are living with celiac disease, but there are only a handful of celiac centers throughout the country. In response to a growing need for educational materials, clinicians at Beth Israel Deaconess Medical Center's Celiac Center have launched CeliacNow, a nutritional management website designed to maximize the health and wellbeing of people living with celiac disease and other gluten-related disorders.

10 Dec 2012

FDA clears Avaxia’s AVX-470 IND for treatment of ulcerative colitis

Avaxia Biologics, Inc., a privately-held biotechnology company developing oral antibody drugs that act locally within the digestive tract, announced today that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for AVX-470 for the treatment of ulcerative colitis.

27 Nov 2012

Insight into how coeliac disease is triggered

For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.

12 Oct 2012

Nottingham expert to study impact of gluten intolerance on patients in the UK

A University of Nottingham expert has been awarded -80,000 by two national charities to study the impact of gluten intolerance on patients in the UK.

27 Sep 2012

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

BioLineRx, a biopharmaceutical development company, announced today that BL-7010, an orally available treatment for celiac disease, was found to be safe and well tolerated in pre-clinical studies conducted to date.

10 Sep 2012

Researchers identify genetic variations linked with onset of Barrett's oesophagus

Genetic variations that are linked with the onset of Barrett's oesophagus (BE), a pre-cancerous condition of the lower end of the gullet, have been identified for the first time. The discovery of variations in regions on two chromosomes makes it possible to develop screening tests for people at high risk of developing the disease.

10 Sep 2012

ImmusanT commences Nexvax2 clinical trials for celiac disease in New Zealand, Australia and the U.S.

ImmusanT announced today that it has initiated clinical trials in New Zealand, Australia and the U.S. to evaluate Nexvax2, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed to re-establish patients' tolerance to the toxic effects of gluten, a protein in wheat, barley and rye, and allow them to return to a normal diet.

5 Sep 2012

Allergy alerts in patient records help improve clinical practice

Allergy alerts in patient records have the potential to significantly improve clinical practice, say Spanish researchers.

3 Aug 2012

Around 1.4 million of Americans with celiac disease are unaware of it

Roughly 1.8 million Americans have celiac disease, but around 1.4 million of them are unaware that they have it, a Mayo Clinic-led analysis of the condition's prevalence has found.

1 Aug 2012

Celiac Disease News and Research

Latest Celiac Disease News and Research

Thought Leaders Consortium discusses new vision for medicine in healthcare

Genetic study defines link between primary sclerosing cholangitis and other autoimmune diseases

New biochemical evidence shows cereal grain sorghum safe food for people with celiac disease

Researchers discover new type of deadly intestinal lymphoma common in Asia

LabCorp launches expanded IBD testing profile

GF foods lack vitamins and nutrients, can be high in fat and calories

Avaxia initiates AVX-470 Phase 1b clinical study in ulcerative colitis

Introducing gluten-containing foods to breast-feeding infants may prevent celiac disease

SQI Diagnostics reports net loss of $1,563,000 for quarter-ended December 31, 2012

Scientists identify aromatic rice with very low arsenic content

Infusions of regulatory T cells turn off autoimmune attack on joints

Beth Israel Deaconess Medical Center introduces CeliacNow website

FDA clears Avaxia’s AVX-470 IND for treatment of ulcerative colitis

Insight into how coeliac disease is triggered

Nottingham expert to study impact of gluten intolerance on patients in the UK

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

Researchers identify genetic variations linked with onset of Barrett's oesophagus

ImmusanT commences Nexvax2 clinical trials for celiac disease in New Zealand, Australia and the U.S.

Allergy alerts in patient records help improve clinical practice

Around 1.4 million of Americans with celiac disease are unaware of it

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Celiac Disease News and Research

Latest Celiac Disease News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in